Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000981
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
6.48×10-06
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.790
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:106m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
f:61m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:669m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.189
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.415
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.542
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.998
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.667
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.671
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Fructosamine
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.402
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Fructosamine
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.577
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
8f:9m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00731
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.807
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.898
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.345
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.0143
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.864
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.128
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.323
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.126
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.284
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.950
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatine kinase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatine kinase
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
1.49×10-07
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00239
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0591
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.263
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.842
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.905
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0845
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.420
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.518
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.758
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:669m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
f:61m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:106m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000368
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.168
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.369
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.710
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.357
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.759
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.509
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.550
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.269
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.515
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.579
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
8f:9m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.388
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00563
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
5f:5m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
40f:45m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.506
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.975
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total bilirubin
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.268
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total bilirubin
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.719
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.000127
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00908
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.600
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.939
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0464
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:669m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
f:61m
|
|
|
NotProcessed |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:106m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglycerides
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglycerides
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.143
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.349
|
Successful |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
1f:1m
|
|
|
NotProcessed |
Sirt3tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.521
|
Successful |
Sirt3tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.986
|
Successful |